FTC appeals ruling in case challenging Illumina's acquisition of GRAIL
FOX Business Flash top headlines for September 2
Check out what’s clicking on FoxBusiness.com
The Federal Trade Commission (FTC) on Friday filed a notice of appeal in its case challenging Illumina's multibillion-dollar acquisition of cancer detection company GRAIL.
The notice of appeal, published on the FTC website, comes a day after an administrative law judge ruled in the DNA sequencing firm's favor. Illumina said Thursday that the judge "rejected the FTC's position that the deal would adversely affect competition in a putative market for multi-cancer early detection (MCED) tests."